MetLife (NYSE:MET – Free Report) had its price target upped by Mizuho from $112.00 to $117.00 in a research report released on Thursday morning,Benzinga reports. Mizuho currently has an outperform rating on the financial services provider’s stock.
A number of other research analysts also recently commented on MET. UBS Group increased their price target on MetLife from $105.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, October 6th. Keefe, Bruyette & Woods upped their target price on MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a research report on Tuesday, August 11th. Piper Sandler increased their target price on MetLife from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Monday, November 9th. Wells Fargo & Company raised their price target on shares of MetLife from $109.00 to $110.00 and gave the stock an “overweight” rating in a research report on Monday, October 12th. Finally, Jefferies Financial Group lifted their price target on shares of MetLife from $103.00 to $115.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Fourteen equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $107.12.
Check Out Our Latest Analysis on MET
MetLife Stock Up 0.8%
MET traded up $0.80 during trading hours on Thursday, reaching $102.67. 2,436,641 shares of the stock traded hands, compared to its average volume of 3,197,036. The firm’s fifty day simple moving average is $98.75 and its two-hundred day simple moving average is $86.90. The company has a market cap of $64.52 billion, a price-to-earnings ratio of 13.39, a PEG ratio of 0.96 and a beta of 0.79. MetLife has a fifty-two week low of $67.33 and a fifty-two week high of $106.72. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.21 and a quick ratio of 0.20.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share for the quarter, beating analysts’ consensus estimates of $2.77 by $0.01. The company had revenue of $20.52 billion during the quarter, compared to analysts’ expectations of $19.86 billion. MetLife had a net margin of 6.21% and a return on equity of 25.71%. The firm’s revenue for the quarter was up 18.2% on a year-over-year basis. During the same period in the prior year, the company posted $2.34 EPS. As a group, analysts forecast that MetLife will post 9.91 earnings per share for the current fiscal year.
MetLife Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be paid a $0.5925 dividend. This represents a $2.37 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Tuesday, November 3rd. MetLife’s dividend payout ratio (DPR) is 30.90%.
MetLife announced that its Board of Directors has authorized a stock buyback plan on Wednesday, August 5th that permits the company to repurchase $3 billion in shares. This repurchase authorization permits the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Share repurchase plans are typically a sign that the company’s board of directors believes its shares are undervalued.
Insider Transactions at MetLife
In other MetLife news, CEO Michel Khalaf sold 187,425 shares of the company’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the sale, the chief executive officer owned 759,013 shares in the company, valued at $78,155,568.61. This represents a 19.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.40% of the stock is owned by insiders.
Institutional Investors Weigh In On MetLife
A number of institutional investors have recently made changes to their positions in MET. Cornermen Financial LLC bought a new position in MetLife during the third quarter worth $470,000. Marshall Wace LLP acquired a new position in MetLife in the third quarter worth $85,084,000. Empowered Funds LLC increased its stake in MetLife by 1.9% during the third quarter. Empowered Funds LLC now owns 99,006 shares of the financial services provider’s stock valued at $9,322,000 after purchasing an additional 1,830 shares during the last quarter. United Southern Bank Trust Department bought a new stake in MetLife during the third quarter valued at $170,000. Finally, Kovack Advisors Inc. raised its holdings in shares of MetLife by 100.0% during the third quarter. Kovack Advisors Inc. now owns 9,494 shares of the financial services provider’s stock worth $895,000 after purchasing an additional 4,746 shares during the period. 94.99% of the stock is currently owned by institutional investors.
Recent MetLife Headlines
These are some of the MET headlines that stood out recently:
- Positive Sentiment: Analysts raised their price targets. Mizuho lifted its target to $117 from $112 and maintained an “outperform” rating; Wells Fargo raised its target to $113 from $110 and kept an “overweight” rating. The higher targets indicate continued analyst confidence and potential upside. Mizuho price target article Wells Fargo price target article
- Neutral Sentiment: MetLife earned workplace recognition. The company was named among the 2026 Fortune World’s Best Workplaces and topped U.S.-based financial services and insurance companies on the list. This may support its reputation as an employer, though the direct impact on near-term earnings is unclear. Fortune workplace ranking article
- Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his position by 19.8%. Insider sales can concern investors, although Khalaf retained 759,013 shares after the transaction. CEO share sale article
MetLife Company Profile
MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.
See Also
- Five stocks we like better than MetLife
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
